Skip to main content

CARGO Therapeutics, Inc.

CRGXDelisted Aug 19, 2025
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001966494

CARGO Therapeutics, Inc. was delisted on Aug 19, 2025; its insiders filed their last Form 4 on Aug 19, 2025; 117 institutions reported holding it in 13F filings for Q2 2025, worth $196.6M in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by CARGO Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for CARGO Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for CARGO Therapeutics, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Henderson JaneDirector–Aug 19, 20250
Dhingra KapilDirector–Aug 19, 20250
Orwin John ADirector–Aug 19, 20250
Lubner David CharlesDirector–Aug 19, 20250
Huber Reid MDirector–Aug 19, 20250
Bassan AbrahamDirector–Aug 19, 20250
Viswanadhan KrishnanDirector–Aug 19, 20250
Radhakrishnan AnupSee Remarks0Aug 19, 20250
Chapman GinaPresident & CEO303,905Mar 18, 20250
Gadam ShishirChief Technical Officer89,480Mar 18, 20250
Laport GinnaChief Medical Officer50,000Mar 18, 20250
Akkaraju Srinivas10% Owner4,415,689IndirectJun 3, 20240
Samsara BioCapital, L.P.10% Owner4,415,689IndirectJun 3, 20240
Samsara BioCapital GP, LLC10% Owner4,415,689IndirectJun 3, 20240
RTW Investments, LP10% Owner5,175,832IndirectJan 16, 20240
Wong Roderick10% Owner5,175,832IndirectJan 16, 20240
Wellington Biomedical Innovation Master Investors (Cayman) II L.P.10% Owner737,000Nov 16, 20230
Third Rock Ventures V, L.P.10% Owner1,807,119IndirectNov 14, 20230
Third Rock Ventures VI, L.P.10% Owner1,807,119IndirectNov 14, 20230
Third Rock Ventures GP V, LP10% Owner1,807,119IndirectNov 14, 20230
Third Rock Ventures GP VI, L.P.10% Owner1,807,119IndirectNov 14, 20230
TRV GP VI, LLC10% Owner1,807,119IndirectNov 14, 20230
TRV GP V, LLC10% Owner1,807,119IndirectNov 14, 20230
Edelman JosephOther: Former 10% Owner333,333IndirectNov 14, 20230
Perceptive Advisors LLCOther: Former 10% Owner333,333IndirectNov 14, 20230
Perceptive Life Sciences Master Fund LtdOther: Former 10% Owner333,333IndirectNov 14, 20230
Perceptive Xontogeny Venture Fund II, LPOther: Former 10% Owner333,333IndirectNov 14, 20230

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 3, 2025 (view filing)Jul 21 dayRadhakrishnan AnupSee RemarksSSale−1.63K$4.18−$6.82K−1.3%120.8K after
May 16, 2025 (view filing)May 142 daysRadhakrishnan AnupSee RemarksSSale−27.4K$3.84−$105.2K−18.3%122.4K after
Apr 8, 2025 (view filing)Apr 35 daysLateRadhakrishnan AnupSee RemarksSSale−1.63K$4.00−$6.52K−2.1%77.3K after
Sep 20, 2024 (view filing)Sep 18-192 daysChapman GinaPresident & CEOSSale−10.1K$25.07−$254.3K−8.9%103.9K after2 lots10b5-1
Sep 20, 2024 (view filing)Sep 182 daysRadhakrishnan AnupChief Financial OfficerSSale−1.60K$25.28−$40.4K−19.9%6.45K after10b5-1
Jun 3, 2024 (view filing)9:45 PM ETMay 304 daysAkkaraju Srinivas and 2 others10% OwnerPPurchase+294.0K$17.00+$5.00M+7.1%4.42M after
Nov 16, 2023 (view filing)7:39 PM ETNov 142 daysAkkaraju Srinivas and 2 others10% OwnerPPurchase+666.7K$15.00+$10.0M+19.3%4.12M after
Nov 14, 2023 (view filing)7:08 PM ETNov 14Same dayThird Rock Ventures V, L.P. and 5 others10% OwnerPPurchase+1.33M$15.00+$20.0M+281.4%1.81M after
Nov 14, 2023 (view filing)4:32 PM ETNov 14Same dayEdelman Joseph and 3 othersOther: Former 10% OwnerPPurchase+666.7K$15.00+$10.0MNew position333.3K after2 lots